Dataset from GSK1550188, A Randomised, Single-blind, Placebo Controlled, Dose Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of GSK1550188 in Japanese subjects with Systemic Lupus Erythematosus (SLE).

本研究旨在评估GSK1550188在患有系统性红斑狼疮（Systemic Lupus Erythematosus, SLE）的日本受试者中的安全性、耐受性、药代动力学（pharmacokinetics, PK）及药效动力学（pharmacodynamics, PD）。